Navigation Links
Mylan Reports a 13% Increase in Second Quarter 2013 Adjusted Diluted EPS to $0.68
Date:8/1/2013

iate to provide additional information to investors to demonstrate the Company's ability to comply with financial debt covenants (which are calculated using a measure similar to adjusted EBITDA) and assess the Company's ability to incur additional indebtedness. Whenever Mylan uses such a non-GAAP measure, it will provide a reconciliation of non-GAAP financial measures to the most closely applicable GAAP financial measure. Investors and other readers are encouraged to review the related GAAP financial measures and the reconciliation of non-GAAP measures to their most closely applicable GAAP measure set forth below and should consider non-GAAP measures only as a supplement to, not as a substitute for or as a superior measure to, measures of financial performance prepared in accordance with GAAP.

Below is a reconciliation of GAAP net earnings attributable to Mylan Inc. and diluted GAAP EPS to adjusted net earnings attributable to Mylan Inc. and adjusted diluted EPS for the three and six months ended June 30, 2013 and 2012 (in millions, except per share amounts): Three Months Ended June 30,Six Months Ended June 30,2013201220132012GAAP net earnings attributable to Mylan Inc. and
diluted GAAP EPS

$

177.7$

0.46$

138.6$

0.33$

284.6$

0.72$

267.6$

0.62Purchase accounting related amortization (included in cost of sales) (a)

85.586.8177.6174.3Litigation settlements, net

6.9(12.2)8.7(10.0)Interest expense, primarily amortization of convertible debt discount

8.97.116.620.5Non-cash accretion and fair value adjustments of contingent consideration liability

(2.0)15.83.824.0Clean energy investment pre-tax loss (b)

3.53.57.97.7Financing related costs (included in other income (expense), net)

8.7—8.7—Acquisition related costs (primarily included in selling, general and administrative expense)

5.2—24.6—Res
'/>"/>

SOURCE Mylan Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23

Related medicine technology :

1. Third Circuit Rules in Mylans Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylans Breach of Contract Claim Against GSK to Trial
2. Mylan to Host Investor Day on Aug. 1, 2013 in New York City
3. Roger Graham Named President of Mylan Specialty
4. Mylan Specialty L.P. Joins Forces with Adrian Peterson and Jo Frost to Launch Anaphylaxis Preparedness Campaign
5. Mylan to Speak at the Goldman Sachs 34th Annual Global Healthcare Conference
6. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
7. Mylan Specialty L.P. Announces Partnership with Baseball Teams Across Country to Raise Awareness of Potentially Life-Threatening Allergies
8. Presenting Sponsor Mylan Specialty L.P. Calls on Communities Nationwide to Join The Food Allergy Research & Education (FARE) Walk for Food Allergy
9. Mylan Reports a 19% Increase in First Quarter 2013 Adjusted Diluted EPS to $0.62
10. Deborah Autor, FDAs Deputy Commissioner for Global Regulatory Operations and Policy, to Join Mylan
11. Mylan Announces $1 Million Gift to The Pittsburgh Promise Scholarship Fund
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Most osteoporosis patients want a choice in the ... sponsored by Mission Pharmacal Company. The survey, conducted by ... support community, revealed that 74 percent of osteoporosis patients ... form other than a pill or a tablet. ...
(Date:1/15/2014)... Corporation (the "Company") (NASDAQ: CLSN ) today ... to purchase an aggregate of approximately $15 million of ... offering, led by a dedicated health care fund. ... these investors pursuant to which the Company agreed to ...
(Date:1/15/2014)... LOUISVILLE, Ky. , Jan. 15, 2014  Manufacturers, ... technologies must be able to protect their most ... (Logo: http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because ... Industry, it steadfastly remains one of the most ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... Pa., June 30, 2011 Endo Pharmaceuticals (Nasdaq: ... study comparing the novel investigational drug axomadol against placebo in ... back pain. The results indicate that axomadol did not meet ... analyses of the data and evaluating the path forward for ...
... 30, 2011 UCB and Harvard University officially launched ... took place in Boston last night in the presence ... (Photo: http://photos.prnewswire.com/prnh/20110630/NY28450 ) The ... and academia, with Harvard scientists continuing their research that ...
Cached Medicine Technology:Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain 2UCB Launches Research Alliance with Harvard University 2UCB Launches Research Alliance with Harvard University 3
(Date:7/10/2014)... health concerns in the United States, with 32 percent ... 2012. As health problems such as childhood obesity grow, ... the problem. , A new study, led by Jenine ... at Washington University in St. Louis, examined the use ... conversations about the issue of overweight kids. , The ...
(Date:7/10/2014)... Human Services (HHS) has announced a three-year grant to ... totaling $4.7 million to support a new national model ... , Titled "Evidence-Conformant Oncology Care," the project will ... care for adult cancer patients with late-stage disease, significant ... , "We believe that the best cancer ...
(Date:7/10/2014)... Up to 70% of Parkinson,s disease (PD) ... quality of life. Some patients have disturbed sleep/wake ... asleep, while other patients may be subject to ... extreme, PD patients may exhibit REM-sleep behavior disorder ... re-enactment, even before motor symptoms appear. A review ...
(Date:7/10/2014)... at the University of Huddersfield could help to improve ... food products such as butter, mayonnaise, yoghurt and ... an international profile for her work. , Katerina gained ... the University and now she has embarked on research ... Vassilis Kontogiorgos, she is investigating the potential of carbohydrates ...
(Date:7/10/2014)... identifying the clinical indicators most strongly associated with concussion ... developing evidence-based guidelines for concussion diagnosis, prognosis, and treatment, ... Neurosurgery , official journal of the ... by Lippincott Williams & Wilkins , a part ... Based on analysis of the best available research data, ...
Breaking Medicine News(10 mins):Health News:Study looks at how Twitter can be used to address specific health issues 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3Health News:Sleep disturbances, common in Parkinson's disease, can be early indicator of disease onset 2Health News:World interest in research work on the benefits of the Okra plant 2Health News:What's a concussion? Review identifies four evidence-based indicators 2Health News:What's a concussion? Review identifies four evidence-based indicators 3
... typically ones headed by a medical doctor rather than a manager. ... makes a good hospital. The research, to be published in ... first of its kind. Its conclusions run counter to a ... -- not those with a medical degree -- at the helm ...
... By pairing an award-winning remote-detection version of NMR/MRI ... designed for microfluidic chips, researchers with the U.S. ... (Berkeley Lab) have opened the door to a ... that would be impractical if not impossible with ...
... , WEDNESDAY, July 6 (HealthDay News) -- Brief, voluntary ... reduce their use of the drug, according to a new ... to these discussions about marijuana was more effective than merely ... drug. Marijuana is a common drug choice for teens ...
... form of brain tumor in people. Research published in ... Design offers a novel way to determine what ... to form. Understanding the problems at the molecular level ... in glioblastoma and ultimately lead to treatments or even ...
... , WEDNESDAY, July 6 (HealthDay News) -- Being satisfied with ... the finding of a new study that included almost 8,000 ... their satisfaction in seven areas of their lives: romantic relationships, ... self. Over a follow-up period of about six years, ...
... ablative radiotherapy and improvements in surgical care in early-stage ... elderly Dutch patients, according to a population-based study presented ... Amsterdam, hosted by the International Association for the Study ... Dutch non-small cell lung cancer (NSCLC) patients increased by ...
Cached Medicine News:Health News:The best hospitals are run by physicians 2Health News:Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 2Health News:Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 3Health News:Berkeley Lab researchers apply NMR/MRI to microfluidic chromatography 4Health News:Talking to Teens May Help Them Cut Back on Pot Smoking 2Health News:What causes brain cancer? 2Health News:Elderly Dutch lung patients' survival improved by new treatment options between 2003-2009 2
... interoperative placement to stent the ... and continent urinary diversions. Supplied ... for one-time use. CAUTION: Periodic ... not remain indwelling more than ...
... a device that provides effective cutting and simultaneous ... to provide the urologist with the same touch ... the approximate speed and the same ease of ... but with a 45% greater zone of ...
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Used for stone manipulation and removal in the renal pelvis under direct vision. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: